首页 | 本学科首页   官方微博 | 高级检索  
     


Efficacy and Safety of Rituximab for the Treatment of Graves' Orbitopathy: A Meta‐analysis of Randomized Controlled Trials
Authors:Wan‐Chen Shen  Chia‐Hwa Lee  El‐Wui Loh  An‐Tsz Hsieh  Lawrence Chen  Ka‐Wai Tam
Affiliation:1. Department of Pharmacy, Taipei Medical University‐Shuang Ho Hospital, New Taipei City, Taiwan;2. College of Pharmacy, Taipei Medical University, Taipei, Taiwan;3. School of Medical Laboratory Science and Biotechnology, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan;4. Comprehensive Cancer Center of Taipei Medical University, Taipei, Taiwan;5. Department of Laboratory Medicine, Taipei Medical University‐Shuang Ho Hospital, Taipei, Taiwan;6. Center for Evidence‐Based Health Care, Department of Medical Research, Taipei Medical University‐Shuang Ho Hospital, New Taipei City, Taiwan;7. Division of Endocrinology & Metabolism, Department of Internal Medicine, Taipei Medical University‐Shuang Ho Hospital, New Taipei City, Taiwan;8. Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan;9. Lake Erie College of Osteopathic Medicine, Bradenton, Florida;10. Division of General Surgery, Department of Surgery, Taipei Medical University‐Shuang Ho Hospital, New Taipei City, Taiwan;11. Department of Surgery, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan;12. Cochrane Taiwan, Taipei Medical University, Taipei, Taiwan
Abstract:
Keywords:Graves' orbitopathy  Graves' ophthalmopathy  thyroid eye disease  glucocorticoids  rituximab
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号